Cardiovascular Science and Clinical Guidance for HCPs in Egypt
This section covers cardiovascular disease topics relevant to healthcare professionals, including thrombosis risk assessment, dyslipidemia management and broader cardiovascular risk-reduction strategies. Validated risk-assessment tools are included to support structured clinical decision-making. Content reflects current understanding of cardiovascular risk stratification and management approaches.
Science in Cardiovascular Diseases
Get a 360º view and stay up-to-date on cardiovascular disease with content selected for you
Updated Treatment Algorithm for Cancer-Associated Thrombosis
This article reviews an updated expert consensus treatment algorithm for managing cancer-associated thrombosis, including how the Khorana risk assessment model informs risk stratification within the pathway. Cancer-associated thrombosis carries distinct management considerations compared with thrombosis unrelated to malignancy, including anticoagulant choice and duration. Healthcare professionals can use this summary to align treatment decisions with current expert recommendations.
RCOG Guidance on Reducing Venous Thromboembolism Risk in Pregnancy
This article summarizes Royal College of Obstetricians and Gynaecologists guidance on reducing venous thromboembolism risk during pregnancy and the puerperium, a period associated with physiologically elevated thrombosis risk. The guidance outlines a structured approach to risk assessment and thromboprophylaxis recommendations across the antenatal and postpartum periods. Healthcare professionals can use this summary to support consistent application of these recommendations in obstetric practice.
Risk Assessment Models
Structured risk assessment allows healthcare professionals to stratify patients by their likelihood of experiencing a cardiovascular or thrombotic event, guiding decisions on prevention intensity and monitoring frequency. Using validated tools rather than clinical impression alone improves consistency in risk categorization across patients. This supports more targeted use of preventive therapies in higher-risk individuals.
Commonly used tools include venous thromboembolism risk scores for hospitalized and surgical patients, as well as pregnancy-specific thrombosis risk assessment models. Each tool is designed for a specific clinical context and patient population, so selecting the appropriate tool matters. These validated scoring systems help translate multiple risk factors into an actionable risk category.
Thrombosis is a mechanistic link across several cardiovascular conditions, including venous thromboembolism, and can also complicate other conditions such as cancer or pregnancy. Managing thrombosis risk is therefore an important component of comprehensive cardiovascular care, not a separate, isolated concern. Healthcare professionals should consider thrombosis risk factors alongside traditional cardiovascular risk factors during patient assessment.
Confirm that you are a healthcare professional to continue reading.
Click login to continue